ABU DHABI, Jan 23 (Reuters) - Abu Dhabi's M42, an artificial intelligence (AI)-powered healthcare company backed by sovereign wealth fund Mubadala, announced a new operating structure on Thursday ...

Khaldoon Al Mubarak, CEO of Mubadala, discusses China's investment potential in the new Trump era. Judge issues nationwide injunction blocking Trump's bid to end birthright citizenship I grew up ...

The Fund seeks to provide investors with a concentrated exposure to a high-quality portfolio of Australian listed companies outside the S&P/ASX 50. On occasion, the Fund may also invest in listed ...

(Bloomberg) -- Private credit has been the best-performing asset class for Mubadala Investment Co. for three years in a row, according to the Abu Dhabi sovereign wealth fund’s deputy group chief ...

Turkish fast grocery delivery company Getir and its largest shareholder, Mubadala, remain in disagreement over a restructuring plan that Abu Dhabi's state investment fund argues is crucial for ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

A founder of Turkish fast-delivery company Getir announced on Wednesday he would pursue legal action against what he called an "illegal coup" by Mubadala, the firm's largest shareholder, which was ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

A strategic move that further supports Mubadala’s efforts to advance the UAE's life sciences sector Following the acquisition of four GlobalOne Healthcare Holding assets, this transaction represents ...

Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary of Ras Al Khaimah-headquartered ...